Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
出版年份 2022 全文链接
标题
Gut Microbial Signatures for Glycemic Responses of GLP-1 Receptor Agonists in Type 2 Diabetic Patients: A Pilot Study
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2022-01-10
DOI
10.3389/fendo.2021.814770
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus
- (2021) Junjie Shang et al. PeerJ
- Associations of plasma trimethylamine N-oxide, choline, carnitine, and betaine with inflammatory and cardiometabolic risk biomarkers and the fecal microbiome in the Multiethnic Cohort Adiposity Phenotype Study
- (2020) Benjamin C Fu et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition
- (2020) Rhys Williams et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Role of gut microbiota in type 2 diabetes pathophysiology
- (2020) Manoj Gurung et al. EBioMedicine
- The Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese Patients?
- (2020) Fabien Magne et al. Nutrients
- The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health
- (2020) Bianca J. Parker et al. Frontiers in Immunology
- Pairing Bacteroides vulgatus LPS Structure with Its Immunomodulatory Effects on Human Cellular Models
- (2020) Flaviana Di Lorenzo et al. ACS Central Science
- Comparative effectiveness of dulaglutide versus liraglutide in Asian type 2 diabetes patients: a multi-institutional cohort study and meta-analysis
- (2020) Kai-Cheng Chang et al. Cardiovascular Diabetology
- Bacteroides vulgatus and Bacteroides dorei Reduce Gut Microbial Lipopolysaccharide Production and Inhibit Atherosclerosis
- (2019) Naofumi Yoshida et al. CIRCULATION
- Glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: real-world evidence from a Mediterranean area
- (2019) Manel Mata-Cases et al. CURRENT MEDICAL RESEARCH AND OPINION
- The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients
- (2019) Yongfei Hu et al. Frontiers in Cellular and Infection Microbiology
- Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2
- (2019) Evan Bolyen et al. NATURE BIOTECHNOLOGY
- Discrepant gut microbiota markers for the classification of obesity-related metabolic abnormalities
- (2019) Qiang Zeng et al. Scientific Reports
- Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
- (2019) Mette Simone Aae Madsen et al. Scientific Reports
- 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes—2020
- (2019) DIABETES CARE
- Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting
- (2018) N. Simioni et al. ACTA DIABETOLOGICA
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- HBA1C CONTROL AND COST-EFFECTIVENESS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INITIATED ON CANAGLIFLOZIN OR A GLUCAGON-LIKE PEPTIDE 1 RECEPTOR AGONIST IN A REAL-WORLD SETTING
- (2018) Carol H. Wysham et al. Endocrine Practice
- Validity of a Short Food Frequency Questionnaire Assessing Macronutrient and Fiber Intakes in Patients of Han Chinese Descent with Type 2 Diabetes
- (2018) Meng-Chuan Huang et al. International Journal of Environmental Research and Public Health
- Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin
- (2018) Nicholas A. Bokulich et al. Microbiome
- A Glucagon-Like Peptide-1 Receptor Agonist Lowers Weight by Modulating the Structure of Gut Microbiota
- (2018) Li Zhao et al. Frontiers in Endocrinology
- Butyricimonas virosa: A rare cause of bacteremia
- (2018) Lidia García-Agudo et al. ANAEROBE
- Regional variation limits applications of healthy gut microbiome reference ranges and disease models
- (2018) Yan He et al. NATURE MEDICINE
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Glycaemic Outcomes in the LEADER Trial
- (2018) Bernard Zinman et al. Diabetes Therapy
- Roseburia spp.: a marker of health?
- (2017) Zohreh Tamanai-Shacoori et al. Future Microbiology
- Mucosal microbiome dysbiosis in gastric carcinogenesis
- (2017) Olabisi Oluwabukola Coker et al. GUT
- Detection of Increased Plasma Interleukin-6 Levels and Prevalence of Prevotella copri and Bacteroides vulgatus in the Feces of Type 2 Diabetes Patients
- (2017) Aline Zazeri Leite et al. Frontiers in Immunology
- An insider's perspective: Bacteroides as a window into the microbiome
- (2017) Aaron G. Wexler et al. Nature Microbiology
- Microbiome Helper: a Custom and Streamlined Workflow for Microbiome Research
- (2017) André M. Comeau et al. mSystems
- Analysis of the cervical microbiome and potential biomarkers from postpartum HIV-positive women displaying cervical intraepithelial lesions
- (2017) Gislaine Curty et al. Scientific Reports
- Characterization of gut microbiota profiles in coronary artery disease patients using data mining analysis of terminal restriction fragment length polymorphism: gut microbiota could be a diagnostic marker of coronary artery disease
- (2016) Takuo Emoto et al. HEART AND VESSELS
- Human gut microbes impact host serum metabolome and insulin sensitivity
- (2016) Helle Krogh Pedersen et al. NATURE
- The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions
- (2016) Michael A Nauck et al. Lancet Diabetes & Endocrinology
- Correlation Between Baseline Characteristics and Clinical Outcomes in a Large Population of Diabetes Patients Treated with Liraglutide in a Real-World Setting in Italy
- (2015) Annunziata Lapolla et al. CLINICAL THERAPEUTICS
- GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
- (2015) Bernardo Yusta et al. DIABETES
- Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes
- (2015) Angus G. Jones et al. DIABETES CARE
- Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis
- (2015) Ji Miao et al. Nature Communications
- Sparse and Compositionally Robust Inference of Microbial Ecological Networks
- (2015) Zachary D. Kurtz et al. PLoS Computational Biology
- Uniting the classification of cultured and uncultured bacteria and archaea using 16S rRNA gene sequences
- (2014) Pablo Yarza et al. NATURE REVIEWS MICROBIOLOGY
- Innate Immune Receptors: Key Regulators of Metabolic Disease Progression
- (2013) Chengcheng Jin et al. Cell Metabolism
- Microbiological diversity of peri-implantitis biofilm by Sanger sequencing
- (2013) Ennyo S. C. da Silva et al. CLINICAL ORAL IMPLANTS RESEARCH
- Non contiguous-finished genome sequence and description of Alistipes obesi sp. nov
- (2013) Perrine Hugon et al. Standards in Genomic Sciences
- Impairment of GLP1-induced insulin secretion: role of genetic background, insulin resistance and hyperglycaemia
- (2012) S. Herzberg-Schäfer et al. DIABETES OBESITY & METABOLISM
- A metagenome-wide association study of gut microbiota in type 2 diabetes
- (2012) Junjie Qin et al. NATURE
- Inferring Correlation Networks from Genomic Survey Data
- (2012) Jonathan Friedman et al. PLoS Computational Biology
- Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
- (2010) Nadja Larsen et al. PLoS One
- BLAST+: architecture and applications
- (2009) Christiam Camacho et al. BMC BIOINFORMATICS
- Dialister succinatiphilus sp. nov. and Barnesiella intestinihominis sp. nov., isolated from human faeces
- (2008) M. Morotomi et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search